Ad
related to: norwegian krone etf symbolView ETF Details of Our "Value" Refined Dividend ETF Primarily Investing in U.S Companies. A Suite of ETFs Backed by 90 Years of Active Management Experience. View ETF Details.
- ETFs Suite
Introducing Six Active, Transparent
ETFs Based on Seasoned Strategies
- ETF Commentary
Find Quarterly Results, Analysis
and Investment Insights. Read More.
- Capital Group Active ETFs
Our Active Approach Now in ETFs
to Pursue Superior Outcomes
- CGGR ETF
A Fund That Takes a Flexible
Approach To Growth Investing.
- ETFs Suite
Search results
1 day ago · NorthX Nickel Corp (NXNIF:QBB) financials, including income statements, growth rates, balance sheets and cash flow information.
1 day ago · On Wednesday, NorthX Nickel Corp (NXNIF:QBB) closed at 0.28, 460.00% above the 52 week low of 0.05 set on May 02, 2024. Data delayed at least 15 minutes, as of May 29 2024 20:46 BST. All markets data located on FT.com is subject to the FT Terms & Conditions.
1 day ago · USD/SEK. 0.46%. USD/NOK. 0.21%. UBS expressed a positive outlook on the NOKSEK currency pair, indicating a potential upside. The firm noted that both the Norwegian Krone (NOK) and the Swedish Krona (SEK) are outperforming against their end-of-second-quarter targets, which are set at 11.70 for the Euro to Norwegian Krone ( EURNOK) and 11.80 for ...
40 minutes ago · Hunter Group ASA - First quarter results 2024. May 30, 2024 at 01:30 am EDT. Oslo, 30 May 2024. Please see the enclosed report for further information. Financial highlights - Q1 2024: Total revenues. USD 6.55m. Total operating expenses. USD 0.66m.
1 hour ago · The shares in Austevoll Seafood ASA will be quoted ex-dividend NOK 4.50 pershare as of today, 30 May 2024. This information is subject to the disclosure requirements pursuant to section5-12 of the Norwegian Securities Trading Act.
1 day ago · Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms.
6 hours ago · During the quarter Lytix generated a revenue of NOK 10.5 million for sale of LTX-315 to Verrica for use in their clinical trial. In April 2024, Lytix successfully raised NOK 50 million in gross proceeds in a share offering primarily directed towards existing shareholders, extending the cash runway into 2025.
Ads
related to: norwegian krone etf symbolView ETF Details of Our "Value" Refined Dividend ETF Primarily Investing in U.S Companies. A Suite of ETFs Backed by 90 Years of Active Management Experience. View ETF Details.
Systematic long/short managed futures strategy investing in commodities and rates. Designed for absolute return and portfolio diversification. Learn more about CTA.
